<DOC>
	<DOC>NCT01516060</DOC>
	<brief_summary>The purpose is to investigate whether HIV and HIV medication can affect certain areas of brain function. This study will look at possible changes in brain function including memory, concentration and thought processes to see if there are any differences between the two doses of efavirenz used in the Encore1 study and also the level of efavirenz in the blood</brief_summary>
	<brief_title>The Neurocognitive Sub-study of Encore1</brief_title>
	<detailed_description />
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>All subjects entering into the main study protocol at participating centres will be eligible to enter this substudy. Existing neurological brain disease Recent (&lt;6months ) head injury Current major depression or psychosis Current alcohol abuse Intended use of recreational drugs during study period Uncontrolled medical conditions deemed to potentially interfere with cognitive function (e.g. uncontrolled diabetes, pyrexial illness, uraemia etc)</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>